The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A

被引:27
作者
Duyndam, MCA [1 ]
van Dam, H [1 ]
Smits, PHM [1 ]
Verlaan, M [1 ]
van der Eb, AJ [1 ]
Zantema, A [1 ]
机构
[1] Leiden Univ, Med Ctr, Mol Carcinogenesis Lab, NL-2333 AL Leiden, Netherlands
关键词
ATF; Jun; SAPK; CBP; transcription; coactivator;
D O I
10.1038/sj.onc.1202584
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adenovirus EIA proteins activate the c-jun promoter through two Jun/ATF-binding sites, jun1 and jun2. P300, a transcriptional coactivator of several AP1 and ATF transcription factors has been postulated to play a role in this activation, Here,,ve present evidence that p300 can control c-jun transcription by acting as a cofactor for ATF2: (1) Over-expression of p300 mas found to stimulate c-jun transcription both in the presence and absence of EIA. (2) Like E1A, p300 activates the c-jun promoter through the jun1 and jun2 elements and preferentially activates the N-terminal domain of ATF2. (3) Co-immunoprecipitation assays of crude cell extracts indicate that endogenous p300/CBP(-like) proteins and ATF2 proteins are present in a multiprotein complex that can bind specifically to the jun2 element, We further demonstrate that the Stress-Activated-Protein-Kinase (SAPK) target sites of ATF2, Thr69 and Thr71 are not required for the formation of the p300/CBP-ATF2 multiprotein complex. These data indicate that E1A does not inhibit all transcription activation functions of p300, and, in fact, cooperates with p300 in the activation of the ATF2 N-terminus.
引用
收藏
页码:2311 / 2321
页数:11
相关论文
共 71 条
[61]   ONCOGENIC AND TRANSCRIPTIONAL COOPERATION WITH HA-RAS REQUIRES PHOSPHORYLATION OF C-JUN ON SERINE-63 AND SERINE-73 [J].
SMEAL, T ;
BINETRUY, B ;
MERCOLA, DA ;
BIRRER, M ;
KARIN, M .
NATURE, 1991, 354 (6353) :494-496
[62]  
Smits PHM, 1996, ONCOGENE, V12, P1529
[63]   ULTRAVIOLET-RADIATION INDUCED C-JUN GENE-TRANSCRIPTION - 2 AP-1 LIKE BINDING-SITES MEDIATE THE RESPONSE [J].
STEIN, B ;
ANGEL, P ;
VANDAM, H ;
PONTA, H ;
HERRLICH, P ;
VANDEREB, A ;
RAHMSDORF, HJ .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1992, 55 (03) :409-415
[64]   DIFFERENTIAL-EFFECTS OF THE ADENOVIRUS-E1A ONCOGENE ON MEMBERS OF THE AP-1 TRANSCRIPTION FACTOR FAMILY [J].
VANDAM, H ;
OFFRINGA, R ;
MEIJER, I ;
STEIN, B ;
SMITS, AM ;
HERRLICH, P ;
BOS, JL ;
VANDEREB, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5857-5864
[65]   HETERODIMER FORMATION OF CJUN AND ATF-2 IS RESPONSIBLE FOR INDUCTION OF C-JUN BY THE 243-AMINO ACID ADENOVIRUS E1A PROTEIN [J].
VANDAM, H ;
DUYNDAM, M ;
ROTTIER, R ;
BOSCH, A ;
DEVRIESSMITS, L ;
HERRLICH, P ;
ZANTEMA, A ;
ANGEL, P ;
VANDEREB, AJ .
EMBO JOURNAL, 1993, 12 (02) :479-487
[66]  
VANDAM H, 1989, ONCOGENE, V4, P1207
[67]   ATF-2 IS PREFERENTIALLY ACTIVATED BY STRESS-ACTIVATED PROTEIN-KINASES TO MEDIATE C-JUN INDUCTION IN RESPONSE TO GENOTOXIC AGENTS [J].
VANDAM, H ;
WILHELM, D ;
HERR, I ;
STEFFEN, A ;
HERRLICH, P ;
ANGEL, P .
EMBO JOURNAL, 1995, 14 (08) :1798-1811
[68]  
VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I
[69]   A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A [J].
Yang, XJ ;
Ogryzko, VV ;
Nishikawa, J ;
Howard, BH ;
Nakatani, Y .
NATURE, 1996, 382 (6589) :319-324
[70]   Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300 [J].
Yao, TP ;
Oh, SP ;
Fuchs, M ;
Zhou, ND ;
Ch'ng, LE ;
Newsome, D ;
Bronson, RT ;
Li, E ;
Livingston, DM ;
Eckner, R .
CELL, 1998, 93 (03) :361-372